LizarBio Therapeutics
Developing cell therapy treatments
- B2B
About LizarBio Therapeutics
Cell therapy company developing transformative treatments for incurable diseases, focusing on Heart Failure and Rett Syndrome Specializes in stem cells cultivation and differentiation
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- são paulo, Brazil
- Founded
- 2013
- Revenue
- $1.1M – $8.5MTamtam estimate
- Website
- lizar.bio
- linkedin.com/company/lizarbio
LizarBio Therapeutics at a glance
LizarBio Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in são paulo, Brazil.
LizarBio Therapeutics was founded in 2013.
LizarBio Therapeutics has 1–10 employees.
LizarBio Therapeutics's revenue is $1.1M – $8.5M (Tamtam estimate).
Frequently asked questions about LizarBio Therapeutics
What is LizarBio Therapeutics's revenue?
Tamtam estimates LizarBio Therapeutics's annual revenue at $1.1M – $8.5M.
How many employees does LizarBio Therapeutics have?
LizarBio Therapeutics has 1–10 employees.
Where is LizarBio Therapeutics headquartered?
LizarBio Therapeutics is headquartered in são paulo, Brazil.
Selling to companies like LizarBio Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies